Amrize (NYSE:AMRZ) Earns "Underperform" Rating from Bank of America

Key Points

• Bank of America reaffirmed its “underperform” rating on Amrize and cut its price target from $50 to $40, implying 6.52% downside from the current price.
• Amrize shares opened at $42.79, near their 52-week low, after the company reported quarterly EPS of $0.88—below the $0.92 consensus estimate. Analysts have a consensus “hold” rating and an average price target of $57.50.
• Analyst sentiment has weakened, with Royal Bank of Canada also downgrading the stock, although insiders bought nearly 19,000 shares worth approximately $884,535 over the past 90 days.

Amrize (NYSE:AMRZ - Get Free Report)'s stock had its "underperform" rating restated by analysts at Bank of America in a research note issued on Wednesday, Benzinga reports. They currently have a $40.00 target price on the stock, down from their previous target price of $50.00. Bank of America's price objective indicates a potential downside of 6.52% from the stock's current price.

Other research analysts have also issued research reports about the stock. Royal Bank Of Canada lowered shares of Amrize from a "sector perform" rating to an "underperform" rating and decreased their target price for the stock from $60.00 to $48.00 in a research report on Monday, August 10th. Oppenheimer dropped their price target on shares of Amrize from $68.00 to $65.00 and set an "outperform" rating for the company in a research report on Tuesday, July 21st. DA Davidson began coverage on Amrize in a research note on Monday, August 24th. They issued a "neutral" rating and a $50.00 price target for the company. Morgan Stanley set a $63.00 price target on Amrize and gave the stock an "overweight" rating in a research report on Monday, June 22nd. Finally, Wells Fargo & Company lowered their price objective on Amrize from $65.00 to $58.00 and set an "overweight" rating on the stock in a research note on Wednesday, July 8th. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, six have issued a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $57.50.

Amrize Stock Down 2.1%

AMRZ opened at $42.79 on Wednesday. The stock has a fifty day moving average of $49.11 and a 200-day moving average of $53.52. The company has a market capitalization of $23.67 billion, a P/E ratio of 19.72, a P/E/G ratio of 0.97 and a beta of 0.12. Amrize has a fifty-two week low of $42.72 and a fifty-two week high of $65.94. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.73 and a current ratio of 1.10.

Amrize (NYSE:AMRZ - Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.88 EPS for the quarter, missing the consensus estimate of $0.92 by ($0.04). Amrize had a net margin of 9.89% and a return on equity of 10.22%. The business had revenue of $3.49 billion during the quarter. On average, equities analysts expect that Amrize will post 2.74 EPS for the current year.

Insider Activity at Amrize

In other news, insider Jaime Hill purchased 1,500 shares of the company's stock in a transaction dated Tuesday, August 11th. The stock was bought at an average cost of $47.12 per share, for a total transaction of $70,680.00. Following the purchase, the insider owned 29,698 shares of the company's stock, valued at approximately $1,399,369.76. The trade was a 5.32% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Baris Oran purchased 3,000 shares of the company's stock in a transaction dated Tuesday, August 11th. The stock was purchased at an average price of $47.38 per share, with a total value of $142,140.00. Following the completion of the purchase, the chief financial officer directly owned 3,000 shares in the company, valued at $142,140. The trade was a ∞ increase in their position. The SEC filing for this purchase provides additional information. In the last ninety days, insiders acquired 18,983 shares of company stock valued at $884,535. 0.54% of the stock is owned by company insiders.

Institutional Trading of Amrize

A number of hedge funds have recently made changes to their positions in the company. MCF Advisors LLC acquired a new position in shares of Amrize in the fourth quarter valued at approximately $27,000. Basepoint Wealth LLC acquired a new stake in Amrize during the 4th quarter worth approximately $33,000. US Bancorp DE acquired a new stake in Amrize during the 3rd quarter worth approximately $38,000. Itau Unibanco Holding S.A. grew its holdings in Amrize by 150.0% during the 4th quarter. Itau Unibanco Holding S.A. now owns 750 shares of the company's stock worth $41,000 after acquiring an additional 450 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd grew its holdings in Amrize by 141.3% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 847 shares of the company's stock worth $46,000 after acquiring an additional 496 shares during the last quarter.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source